Emcure Pharma gets USFDA Warning Letter for Manufacturing Violations at Pune plant Medical Dialogues Bureau16 Aug 2019 9:45 AM ISTIn the letter, the USFDA said inspectors during February 11-20 this year found significant deviations from standard manufacturing practices at Emcure...
Sun Pharma records Total Revenue of Rs 8374.36 crore for June quarter Medical Dialogues Bureau16 Aug 2019 9:30 AM ISTMumbai: India's largest drugmaker Sun Pharmaceutical Industries Ltd. (Sun Pharma) recently reported a consolidated net profit of Rs 1,387.48 crore...
Wish to see India excel in pharmaceutical research, says Delhi Deputy CM Manish Sisodia Medical Dialogues Bureau15 Aug 2019 9:50 AM IST Addressing students of the Delhi Pharmaceutical Sciences and Research University (DPSRU), Pushp Vihar, here, Manish Sisodia said that India is placed...
Natco Pharma gets 6 USFDA observations for API facility near Hyderabad Medical Dialogues Bureau13 Aug 2019 1:16 PM ISTNatco Pharma said it will provide due justifications and corrective action plan within the next 15 working days to address the USFDA observations.NEW...
Indoco Remedies successfully completes USFDA inspection of CRO Anacipher in Hyderabad Medical Dialogues Bureau13 Aug 2019 9:45 AM IST"This is the fourth successive USFDA inspection with ZERO 483 for our CRO – AnaCipher," stated Ms Aditi Kare Panandikar, Managing Director, Indoco...
Natco Pharma to focus to scale up Cancer treatment biz in China: MD VC Nannapaneni Medical Dialogues Bureau12 Aug 2019 12:26 PM ISTNew Delhi: Natco Pharma is focusing on filing of cancer treatment drugs in China, the world's second largest pharmaceutical market, as part of its...
Canada enacts drug price crackdown, in blow to pharmaceutical industry Medical Dialogues Bureau11 Aug 2019 9:00 AM ISTThe changes are the biggest reform to Canada's drug price regime since 1987 and could eventually cut the earnings of drugmakers in the United States,...
Zydus Cadila total income up by 21 percent to Rs 3496 crore in Q1 Medical Dialogues Bureau10 Aug 2019 12:43 PM ISTDuring the quarter, Zydus Cadila entered into a marketing alliance with SIFI, the Italian leader in the development of therapeutic solutions for...
Bayer buys BlueRock in USD 600 million bet on stem cell therapies Medical Dialogues Bureau9 Aug 2019 9:00 AM ISTFRANKFURT: German drugmaker Bayer is paying up to $600 million for full control of cell therapy developer BlueRock Therapeutics, stepping up...
Bayer Rivaroxaban tablets win CDSCO Committee nod for waiver of local clinical trial; directed to carry Phase IV trial Medical Dialogues Bureau8 Aug 2019 5:28 PM ISTNew Delhi: The apex drug regulatory body, Central Drugs Standard Control Organisation's (CDSCO) Technical Committee has recommended for grant of...
Cadila Healthcare gets OAI letter from USFDA for Moraiya facility Medical Dialogues Bureau8 Aug 2019 10:00 AM ISTThe company has received a letter from the USFDA classifying the inspection conducted at its Moraiya facility from April 22 to May 3 as OAI, Cadila...
GSK ends Ebola vaccine RnD; transfers license to US institute Medical Dialogues Bureau8 Aug 2019 9:30 AM ISTGSK had put its Ebola vaccine work on hold after it was unable to progress the product through the final stage, or Phase III, clinical trials toward...
